Novel Inflammation-Based Prognostic Score for Predicting Survival in Patients with Metastatic Urothelial Carcinoma.
We developed a novel inflammation-based model (NPS), which consisted of a neutrophil to lymphocyte ratio (NLR) and platelet count (PC), for assessing the prognostic role in patients with metastatic urothelial carcinoma (UC).We performed a retrospective analysis of patients with metastatic UC who und...
Main Authors: | Yu-Li Su, Meng-Che Hsieh, Po-Hui Chiang, Ming-Tse Sung, Jui Lan, Hao-Lun Luo, Chun-Chieh Huang, Cheng-Hua Huang, Yeh Tang, Kun-Ming Rau |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5226814?pdf=render |
Similar Items
-
The Prognostic Impact of Histopathological Variants in Patients with Advanced Urothelial Carcinoma.
by: Meng-Che Hsieh, et al.
Published: (2015-01-01) -
Prognostic impact of tumor infiltrating lymphocytes on patients with metastatic urothelial carcinoma receiving platinum based chemotherapy
by: Hui-Shan Huang, et al.
Published: (2018-05-01) -
Prognostic significance of inflammation-based prognostic scoring in patients with upper urinary tract urothelial carcinoma
by: Taisuke Suyama, et al. -
Metastatic Urothelial Carcinoma of the Bladder with Lymph Node-only Metastasis Treated with M-VAC (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) has a Better Survival than GC (Gemcitabine and Cisplatin)
by: Meng-Che Hsieh, et al.
Published: (2014-12-01) -
Prognostic Effects and Regulation of Activin A, Maspin, and the Androgen Receptor in Upper Urinary Tract Urothelial Carcinoma
by: Kun-Ming Rau, et al.
Published: (2012)